These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of maternal age at birth on breast cancer risk factors in daughters. A hypothesis on the role of oocyte, mitochondrial-related chromosomal instability. van Noord PA. IARC Sci Publ; 2002; 156():315-7. PubMed ID: 12484196 [No Abstract] [Full Text] [Related]
7. [Etiological factors and formation of high-risk groups for breast cancer]. Dymarskiĭ LIu, Semiglazov VF. Sov Med; 1976 Jun; (6):77-82. PubMed ID: 798314 [No Abstract] [Full Text] [Related]
8. [Risk of breast carcinoma at various ages in women in relation to reproduction and menstruation]. Wu GL. Zhonghua Liu Xing Bing Xue Za Zhi; 1986 Apr; 7(2):65-9. PubMed ID: 3742569 [No Abstract] [Full Text] [Related]
9. An attempt at eliminating the high risk group of breast cancer on the basis of the discriminating analysis. Wolynska M. Arch Geschwulstforsch; 1977 Apr; 47(7):634-40. PubMed ID: 606198 [No Abstract] [Full Text] [Related]
11. [Female sex hormones increase the risk of breast cancer]. Vatten L. Tidsskr Nor Laegeforen; 1998 Aug 20; 118(19):2969-74. PubMed ID: 9748837 [Abstract] [Full Text] [Related]
12. Breast cancer and risk factors in an African population: a case referent study. Amir H, Makwaya CK, Aziz MR, Jessani S. East Afr Med J; 1998 May 20; 75(5):268-70. PubMed ID: 9746995 [Abstract] [Full Text] [Related]
13. [Psychosocial stress and breast-cancer risk]. Wenderlein JM. Med Welt; 1978 Dec 08; 29(49):1911-4. PubMed ID: 732562 [No Abstract] [Full Text] [Related]
14. [Urinary excretion of estrogens in women with bleeding during climacteric and in menopause]. Grudzień M. Pol Tyg Lek; 1970 Sep 08; 25(39):1447-9. PubMed ID: 5470643 [No Abstract] [Full Text] [Related]
15. Multistage models for carcinogenesis. Moolgavkar S. J Natl Cancer Inst; 1980 Aug 08; 65(2):215-6. PubMed ID: 6931265 [No Abstract] [Full Text] [Related]
16. Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study. Chang-Claude J, Andrieu N, Rookus M, Brohet R, Antoniou AC, Peock S, Davidson R, Izatt L, Cole T, Noguès C, Luporsi E, Huiart L, Hoogerbrugge N, Van Leeuwen FE, Osorio A, Eyfjord J, Radice P, Goldgar DE, Easton DF, Epidemiological Study of Familial Breast Cancer (EMBRACE), Gene Etude Prospective Sein Ovaire (GENEPSO), Genen Omgeving studie van de werkgroep Hereditiair Borstkanker Onderzoek Nederland (GEO-HEBON), International BRCA1/2 Carrier Cohort Study (IBCCS) collaborators group. Cancer Epidemiol Biomarkers Prev; 2007 Apr 08; 16(4):740-6. PubMed ID: 17416765 [Abstract] [Full Text] [Related]
17. [Pathogenic factors of benign breast tumors]. Yao FY. Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Feb 08; 6(1):33-5. PubMed ID: 3995572 [No Abstract] [Full Text] [Related]
18. Risk of breast cancer according to the status of HER-2/neu oncogene amplification. Huang WY, Newman B, Millikan RC, Conway K, Hulka BS, Schell MJ, Liu ET. Cancer Epidemiol Biomarkers Prev; 2000 Jan 08; 9(1):65-71. PubMed ID: 10667465 [Abstract] [Full Text] [Related]
19. [Menarche, menstruation and menopause in breast cancer patients]. Burány B. Med Pregl; 1982 Jan 08; 35(3-4):121-5. PubMed ID: 7144702 [No Abstract] [Full Text] [Related]
20. The perimenopause: physiologic correlates and clinical management. Upton GV. J Reprod Med; 1982 Jan 08; 27(1):1-16, 17-28. PubMed ID: 7047734 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]